Trials / Completed
CompletedNCT04593355
HCV Epidemiological Survey in China Rural Area
HCV Epidemiological Survey of Chinese in Northeast Rural Area Which Have Injection History
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,068 (actual)
- Sponsor
- The First Hospital of Jilin University · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the morbidity of hepatitis C with Chinese population.
Detailed description
Hepatitis C virus (HCV) infection rate in China is about 3%, which means about 30 million patients. More importantly, many of those patients with chronic hepatitis C eventually develop cirrhosis and hepatocellular carcinoma(HCC).Our survey found the rate of hepatitis c infection in northeastern China without intervention is 34.3%, due to the abuse of caffeine sodium benzoate. This population has the similar mode of transmission, which is a fine study of the natural outcome hepatitis C. We plan to carry out epidemiological studies for this population, review of the influencing factors of the disease, and analyze the host factors that can effect the prognosis.
Conditions
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2020-10-20
- Last updated
- 2020-10-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04593355. Inclusion in this directory is not an endorsement.